Press release
Efficacy Testing Market worth $333 million by 2025 - Leading Key Players are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), WuXi AppTech (China), and SGS (Switzerland).
Efficacy Testing Market
Browse in-depth TOC on "Efficacy Testing Market"
102 – Tables
30 – Figures
142 – Pages
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=51479831&utm_source=openpr&utm_medium=paidpr
The growth of this market is mainly driven by the increasing use of surface disinfectants and preservatives in pharma, biopharma, and cosmetics industries for contamination control and product stability; growing preference for outsourcing efficacy testing; and the rising adoption of the QbD approach.
Surface test method accounted for the largest share of disinfectant efficacy testing market
Based on method, the disinfectant market is segmented into surface test and suspension test methods,. In 2019, the surface test method segment accounted for the largest share of disinfectant market. The growth of this segment is majorly attributed to factors such as the rising burden of cancer and the favorable reimbursement scenario for efficacy testing tests.
The antimicrobial/preservative efficacy testing segment accounted for the fastest-growing service type segment of the market
Based on service type, the efficacy testing market is segmented into antimicrobial/preservative efficacy testing (AET/PET) and disinfectant efficacy testing. In 2019, the antimicrobial/preservative efficacy testing (AET/PET) segment is estimated to grow at the highest CAGR during the forecast period. The growth of this segment is majorly attributed to increasing use of preservatives in pharmaceutical and cosmetic industry.
Get 10% Customization on this Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=51479831&utm_source=openpr&utm_medium=paidpr
North America accounted for the largest share of the efficacy testing market
North America accounted for the largest share of the market, followed by Europe in 2019. The growth in this regional market can be attributed to the presence of a well established pharmaceutical industry in the region, the high R&D expenditure, a strong presence of major service providers, and rising outsourcing of analytical testing (including efficacy testing) by pharmaceutical and cosmetic companies in the region.
The prominent players operating in the efficacy testing market are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), WuXi AppTech (China), and SGS (Switzerland).
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=51479831&utm_source=openpr&utm_medium=paidpr
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Efficacy Testing Market worth $333 million by 2025 - Leading Key Players are Eurofins Scientific (Luxembourg), Charles River Laboratories (US), WuXi AppTech (China), and SGS (Switzerland). here
News-ID: 2224677 • Views: …
More Releases from MarketsandMarkets™
Feed Premix Market, Global Industry Size Forecast
The global feed premix market size is estimated to be valued at USD 24.3 billion in 2021 and is projected to reach a value of USD 32.9 billion by 2026, growing at a CAGR of 6.2% during the forecast period. The growth of this market is attributed to increasing awareness about feed quality, and the implementation of innovative animal husbandry practices to improve meat quality are the important drivers for…
Water-soluble Fertilizers Market is Expected to Grow $23.9 billion in 2028
According to a research report "Water-soluble Fertilizers Market by Type (Nitrogenous, Phosphatic, and Potassic), Mode of Application (Foliar and Fertigation), Form (Dry and Liquid), Crop Type (Field Crop, Horticulture Crops, Turf & ornaments) and Region - Global Forecast to 2028" published by MarketsandMarkets, the water-soluble fertilizers market is estimated at USD 18.3 billion in 2023 and is projected to reach USD 23.9 billion in 2028, at a CAGR of 5.5%.…
Population Health Management (PHM) Market worth $53.3 billion by 2027 - Leading …
Population Health Management (PHM) Market is projected to grow from USD 27.8 billion in 2022 to USD 53.3 billion by 2027, at a CAGR of 13.9% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Growth in this market is driven by the opportunities offered by the emerging markets in healthcare. However, lack of data management, and interoperability issues are expected to challenge the growth of this…
Veterinary Pain Management Market worth $2.5 billion - Leading Key Players are B …
Veterinary Pain Management Market is projected to grow from USD 1.8 billion in 2022 to USD 2.5 billion by 2027, at a CAGR of 6.7% from 2022 to 2027, according to a new report by MarketsandMarkets™. The Pain is the physiological term to describe the chemical processes that are at work in the body that receive a stimulus, modify it, and transfer it to the brain for interpretation and reaction.…
More Releases for Efficacy
Restoring Solar Panel Efficacy With Golden State Pressure Washing
San Jose, CA - Solar panels provide San Jose's residents and business owners with an efficient way of generating electricity. By turning sunlight into power, property owners save money on their property bills and reduce their reliance on fossil fuels. It is for this reason that maintaining solar panel cleanliness is important. When solar panels accumulate layers of debris, it hinders their ability to generate electricity. Additionally, dirty solar panels…
Pharmaceutical Quality Control Market: Ensuring Safety and Efficacy
In the dynamic pharmaceutical industry, ensuring the safety and efficacy of drugs is paramount. Pharmaceutical quality control (QC) plays a vital role in ensuring that medications are produced consistently to meet high standards. As the pharmaceutical industry continues to expand, the significance of quality control in drug manufacturing is increasingly important, leading to substantial growth in the pharmaceutical quality control market. This article explores the market size, share, evolution, trends,…
Efficacy of Combination Therapy in Hematologic Malignancies
Combination therapy has proven to be a highly effective approach in the treatment of hematologic malignancies, including leukemia, lymphoma, and multiple myeloma. By using multiple therapeutic agents with different mechanisms of action, combination therapy can enhance treatment efficacy, overcome resistance, and improve patient outcomes.
Download Report:
https://www.kuickresearch.com/report-cancer-antibody-combinations-therapy-cancer-antibody-combination-monoclonal-antibodies-combination-drug-conjugate-antibodies-combination
One of the primary reasons for the success of combination therapy in hematologic malignancies is the ability to target cancer cells through multiple pathways. Hematologic…
Mechanisms and Efficacy of Claudin 18.2 Antibodies
The development and implementation of Claudin 18.2 antibodies in cancer therapy have introduced new mechanisms and demonstrated significant efficacy. Claudin 18.2, a tight junction protein, is overexpressed in several cancers, making it an ideal target for precision oncology. This article explores the mechanisms through which Claudin 18.2 antibodies operate and their efficacy in treating cancer.
Download Report:
https://www.kuickresearch.com/report-caludin-18-2-cldn-18-2-target-protein-cancer-antibodies-cldn-immmunotherapy-claudin-expression-targeting-claudin
Claudin 18.2 is selectively expressed in cancers such as gastric, pancreatic, and ovarian cancers,…
DLL3 Antibody-Drug Conjugates: Mechanisms and Efficacy
Antibody-drug conjugates (ADCs) represent a revolutionary approach in cancer treatment, combining the targeting capabilities of antibodies with the cytotoxic power of chemotherapy. DLL3 (Delta-Like Ligand 3) has emerged as a promising target for ADCs, particularly in the treatment of small cell lung cancer (SCLC) and other neuroendocrine tumors. This article explores the mechanisms and efficacy of DLL3 ADCs, shedding light on their potential in modern oncology.
Download Report:
https://www.kuickresearch.com/report-dll3-targeted-therapies-dll3-cancer-therapies-dll3-protien-dll3-cancer-drugs-delta-like-ligand-3-dll3-gene-dll3-expression-dll3-amgen-dll3-inhibitor
DLL3 is a…
Multivalent Antibodies: Multiple Targets, Enhanced Efficacy
The advent of multivalent antibodies has revolutionized the landscape of targeted therapeutics, offering the ability to engage multiple targets simultaneously and thus enhancing therapeutic efficacy. These innovative molecules are engineered to bind to several antigens or epitopes, providing a comprehensive approach to treatment that addresses the complexity and heterogeneity of various diseases, particularly cancer.
Download Bispecific, Trispecific and Tetraspecific Antibodies Report:
https://www.kuickresearch.com/ccformF.php?t=1721642510
One of the primary benefits of multivalent antibodies is their ability…
